CENTOGENE

Behind every diagnostic journey is a team 👥✨ Within the CENTOGENE APAC Office, our team works across science, operations, communications, and customer support to connect APAC healthcare communities with CENTOGENE’s global genomic expertise. From the first conversation to diagnostic support, we are here to guide with clarity and care, bringing precision medicine to you. #CENTOGENE #APAC #PrecisionMedicine #GeneticDiagnostics #Genomics Andy Chang Emily Liang Tina Wan Wei Hung Chuang Cheng-Kai Huang, Dr. rer. nat Jennifer Fransisca (鍾佩倪)

We're excited to share that CENTOGENE will be attending SSIEM 2026, the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, in Helsinki, Finland.   As one of the leading international events in inborn errors of metabolism, SSIEM brings together healthcare professionals, researchers, and industry leaders to exchange knowledge and explore the latest scientific and technological advances shaping the future of metabolic disease diagnosis and care.   This year, five members of our team will be attending, and we're proud to be contributing to the scientific programme throughout the congress. Our team attending:   Tobias Böttcher,MD., Director Clinical Neurogenetics Martin Shumanov, Head of Sales Northern Europe Arianda Abazi, Regional Manager Nordics Claudia Cozma, Director Scientific Solutions & Pharma Partnerships Paulo Braga, Senior Director, Business Development - Pharma Business Steffen Fischer, Head of R&D Biochemistry   We look forward to connecting with colleagues and partners across the metabolic disease community and discussing how genetic insights can help advance precision medicine and improve patient outcomes.   📅 August 25–28, 2026 📍 Helsinki, Finland   #SSIEM2026 #InbornErrorsOfMetabolism #PrecisionMedicine #Genetics #Healthcare #RareDisease #CENTOGENE

What changes if the DNA doesn't? The answer lies in the evidence 💡 As scientific knowledge advances through published research, clinical data, and updated interpretation guidelines, our understanding of genetic variants continues to evolve This is why variant reclassification is an essential part of accurate genetic diagnostics #RareDisease #Genetics #VariantReclassification #PrecisionMedicine

🧬 Connecting Innovation and Community Impact 🌍 As Germany and Taiwan are both at the forefront of #biotech and #healthcare innovation, meaningful progress goes hand in hand with community engagement and social responsibility. Our Chief Representative & Executive Director, Dr. Eva Langerbeck was pleased to welcome representatives from CENTOGENE APAC and the Taiwan Foundation for Rare Disorders (TFRD) to the German Trade Office Taipei to discuss their ongoing efforts to improve access to #RareDisease diagnostics. 🤝 CENTOGENE is a German life sciences company specializing in rare disease diagnostics and opened its Taiwan office in July 2026. In the spirit of its 20th anniversary, the company partnered with TFRD to support Taiwan’s rare disease community. TFRD was founded in 1999 as an advocacy group for patients with rare diseases in Taiwan.  Through this collaboration, patients can access advanced testing solutions that go beyond conventional methods and find answers that were previously out of reach. 🔬 Looking ahead, we explored opportunities to further strengthen cooperation between Germany’s and Taiwan’s biotech and healthcare sectors, fostering innovation while creating meaningful impact for patients and communities alike. Many thanks to:  ▪️ Andy Chang CEO Asia Pacific, CENTOGENE  ▪️ Emily Liang, General Manager North East Asia, CENTOGENE   ▪️ Ruth Kuan-Ju Chen, Executive Director, TFRD  ▪️ Yung-Hsiang Yang, Deputy Executive Director, TFRD 🧬 連結創新與社會影響力 🌍 德國與台灣皆位居 #生技 與 #醫療保健 創新的前沿，而真正有意義的進步，也離不開社會參與與責任的共同推動。 德國經濟辦事處處長蘭依樺博士很高興於台北接待權拓基因股份有限公司（CENTOGENE APAC）及台灣罕見疾病基金會（TFRD）的代表，雙方就持續提升罕見疾病診斷的可及性進行交流與討論。🤝 權拓基因是一家專注於罕見疾病診斷的德國生命科學公司，並於2026年7月在台灣設立辦事處。適逢成立 20 週年，權拓基因與台灣罕見疾病基金會展開合作，共同支持台灣罕見疾病患者社群。台灣罕見疾病基金會成立於 1999 年，長期致力於為台灣罕見疾病患者發聲，並提供相關支持與協助。 透過此次合作，患者將有機會取得超越傳統檢測方式的先進診斷方案，為過去難以確診的病例提供更多可能，也讓更多患者有機會找到答案。🔬 展望未來，我們也探討了進一步深化德台生技與醫療保健領域合作的機會，攜手推動創新，同時為患者及社群帶來更具意義的影響。 誠摯感謝以下代表： ▪️權拓基因亞太區執行長張博文先生  ▪️權拓基因東北亞區總經理梁瓈方梁瓈方女士  ▪️財團法人罕見疾病基金會執行長陳冠如女士  ▪️財團法人罕見疾病基金會副執行長楊永祥先生

🎥 MRSi recap! A quick look back at the Midwest Reproductive Symposium international (MRSi), where reproductive health, innovation, and scientific collaboration took center stage. We’re excited to share a short interview featuring Dr. Nasser Al-Asmar Piñar, MSc., Ph.D., VP Scientific and Medical Affairs – Reproductive Health at CENTOGENE, in conversation with Dr. Angeline Beltsos, Executive Chair Member of MRSi. 🧬 CENTOGENE Reproductive Health in the spotlight! Discover Dr. Nasser Al-Asmar Piñar, MSc., Ph.D. insights, hear what’s shaping the future of reproductive health, and get a sneak peek at what’s next. 😉 ▶️ Watch the short interview of this great conversation! #MRSi #ReproductiveHealth #CENTOGENE #MedicalInnovation #GeneticTesting #Fertility #HealthcareInnovation #ScientificResearch

🌍 The CENTOGENE website is now more accessible worldwide. We've expanded our multilingual experience, with 4 languages now available: 🇬🇧 English (US, Canada, Europe & Global) 🇪🇸 Spanish (Spain & LATAM Region) PT Brazilian Portuguese (Brazil & Portugal) 🇹🇼 Traditional Chinese (APAC Region) This enhancement strengthens our commitment to improving the customer experience by providing region-specific communication and tailored content for physicians, patients, and pharma partners worldwide.   Explore CENTOGENE website in your preferred language. www.centogene.com  

Behind every rare disease diagnosis is a story. A family searching for answers. Parents navigating uncertainty. Patients hoping that one more test, one more appointment, might finally bring clarity. These are the stories that remind us why our work matters. As CENTOGENE celebrates 20 years of advancing rare disease diagnostics, opening our APAC office in Taiwan represents more than expanding our presence. It reflects our commitment to standing alongside Taiwan's rare disease community and supporting families throughout their diagnostic journey. Through our collaboration with the 𝗧𝗮𝗶𝘄𝗮𝗻 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 (𝗧𝗙𝗥𝗗), we hope to help more patients gain access to advanced genetic testing and move one step closer to the answers they have been waiting for. This commitment continues through a new initiative offering 𝗖𝗲𝗻𝘁𝗼𝗚𝗲𝗻𝗼𝗺𝗲 𝗠𝗢𝘅 𝟭.𝟬 to eligible Taiwanese patients who remain undiagnosed after previous Whole Exome Sequencing (WES). Learn more about our collaboration and ongoing commitment to Taiwan's rare disease community: https://lnkd.in/ghf3rjZ4  #RareDisease #GeneticTesting #PrecisionMedicine #Taiwan #Healthcare Andy Chang Emily Liang Ruth Kuan-Ju Chen

🧬 CENTOGENE and Pomorski Uniwersytet Medyczny w Szczecinie (PUM) — together for children with rare diseases Behind every diagnosis is a family waiting for answers. That's why our partnership with PUM means so much to us and why it continues. We've just signed a new memorandum with PUM, renewing our shared commitment to help more children with rare diseases finally get the answers they've been searching for. ✒️ The agreement was signed by our Prof. Peter Bauer, Chief Medical Officer and Head of Genomics at CENTOGENE, and PUM Rector Prof. Leszek Domański, with Prof. Maria Gizewska, Head of PUM's Department of Pediatrics, Rare Diseases and Metabolic Medicine, standing alongside them. 🔬 Since 2019, nearly 1,400 studies have touched the lives of over 1,000 young patients and their families each one a step closer to clarity, care, and hope. Now we're going further together: deeper diagnostics, new research projects, molecular consultations, and the most advanced genomic technologies available, all in service of the children who need them most. Because every child deserves an answer. 💙

Today is World Embryologists Day, a time to celebrate the dedication, expertise, and compassion of embryologists who play a vital role in the journey toward parenthood. Every IVF journey is unique. Behind every treatment cycle are individuals and couples carrying hope, navigating uncertainty, and often overcoming years of emotional challenges. At CENTOGENE, we are proud to support fertility specialists and their patients with our expanded reproductive genetics portfolio, combining innovation and precision medicine to help guide informed decisions throughout the fertility journey and support the path toward successful reproductive outcomes. Learn more about how we can support your reproductive genetics journey: